<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00901056</url>
  </required_header>
  <id_info>
    <org_study_id>ED-ESWT</org_study_id>
    <nct_id>NCT00901056</nct_id>
  </id_info>
  <brief_title>Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction</brief_title>
  <official_title>Feasibility Study to Investigate the Effect of Low Intensity Shockwaves on Patients With Erectile Dysfunction Resulted From Vascular Origin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medispec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medispec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low intensity shockwaves have been proven in animal studies to induce local growth of new
      blood vessels from existing ones.

      The hypothesis of this study is that shockwave therapy could improve the symptoms of patients
      with erectile dysfunction resulted from a vascular origin and respond to PDE-5 inhibitors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to the penile
      tissue. Shockwaves are created by a special generator and are focused using a specially
      designed shockwave applicator apparatus. The shockwaves are delivered trough the applicator
      covering the corpora cavernosa of the penis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IIEF score</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rigid Score (RS)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Erection Questionnaire (QEQ)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Esteem And Relationship Questionnaire (SEAR)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erectile Dysfunction Inventory of Treatment Satisfaction (EDIT)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side Effects</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Treated Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive actual shockwave treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal Shockwave Therapy</intervention_name>
    <description>Energy Density - 0.02 - 0.15 mJ/mm2</description>
    <arm_group_label>Treated Group</arm_group_label>
    <other_name>Vascuspec</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ED of more than 6 months

          -  At least 50% unsuccessful to attempt sexual intercourse for 4 times at 4 different
             days

          -  Positive response to PDE-5 inhibitors

          -  IIEF-5 domain score of 12-20 denoting mild to severe ED

          -  Non-Neurological pathology

          -  Stable heterosexual relationship for more than 3 months

        Exclusion Criteria:

          -  NPT - normal/flat

          -  Prior prostatectomy surgery

          -  Any cause of ED other than vascular related

          -  Any unstable medical, psychiatric, spinal cord injury, penile anatomical abnormalities

          -  Clinically significant chronic hematological disease

          -  Cardiovascular conditions that prevent sexual activity

          -  History of heart attack, stroke or life-threatening arrhythmia within the prior 6
             months.

          -  Cancer within the past 5 years.

          -  Anti-androgens, oral or injectable androgens

          -  Use of any treatment for ED within 7 days of screening including oral medications,
             vacuum devices, constrictive devices, injections or urethral suppositories
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoram Vardi, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2009</study_first_submitted>
  <study_first_submitted_qc>May 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2009</study_first_posted>
  <last_update_submitted>January 23, 2011</last_update_submitted>
  <last_update_submitted_qc>January 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Yoram Vardi</name_title>
    <organization>Rambam Medical Center</organization>
  </responsible_party>
  <keyword>ED</keyword>
  <keyword>Erectile Dysfunction</keyword>
  <keyword>Erectile dysfunction treated with PDE-5 inhibitors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

